- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.00 Å
- Oligo State
- homo-octamer
- Ligands
- 8 x MG: MAGNESIUM ION(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.2: 14 residues within 4Å:- Chain A: W.14, L.22, E.23, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106
- Chain H: M.111
- Ligands: MG.1
13 PLIP interactions:13 interactions with chain A- Hydrogen bonds: A:G.74, A:G.74, A:S.75, A:G.76, A:G.76, A:K.77, A:T.78, A:S.79, A:Q.106, A:Q.106
- Salt bridges: A:K.77, A:K.77
- pi-Stacking: A:F.43
ATP.6: 14 residues within 4Å:- Chain A: M.111
- Chain B: W.14, L.22, E.23, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106
- Ligands: MG.5
11 PLIP interactions:11 interactions with chain B- Hydrogen bonds: B:E.23, B:G.74, B:S.75, B:G.76, B:G.76, B:K.77, B:T.78, B:S.79
- Salt bridges: B:K.77, B:K.77
- pi-Stacking: B:F.43
ATP.9: 14 residues within 4Å:- Chain C: W.14, L.22, E.23, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106
- Chain F: M.111
- Ligands: MG.8
13 PLIP interactions:13 interactions with chain C- Hydrogen bonds: C:G.74, C:G.74, C:S.75, C:G.76, C:G.76, C:K.77, C:T.78, C:S.79, C:Q.106, C:Q.106
- Salt bridges: C:K.77, C:K.77
- pi-Stacking: C:F.43
ATP.13: 14 residues within 4Å:- Chain C: M.111
- Chain D: W.14, L.22, E.23, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106
- Ligands: MG.12
13 PLIP interactions:13 interactions with chain D- Hydrogen bonds: D:E.23, D:E.23, D:T.73, D:G.74, D:S.75, D:G.76, D:G.76, D:K.77, D:T.78, D:S.79
- Salt bridges: D:K.77, D:K.77
- pi-Stacking: D:F.43
ATP.16: 14 residues within 4Å:- Chain D: M.111
- Chain E: W.14, L.22, E.23, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106
- Ligands: MG.15
14 PLIP interactions:14 interactions with chain E- Hydrogen bonds: E:G.74, E:G.74, E:S.75, E:G.76, E:G.76, E:K.77, E:T.78, E:T.78, E:S.79, E:Q.106, E:Q.106
- Salt bridges: E:K.77, E:K.77
- pi-Stacking: E:F.43
ATP.20: 14 residues within 4Å:- Chain E: M.111
- Chain F: W.14, L.22, E.23, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106
- Ligands: MG.19
11 PLIP interactions:11 interactions with chain F- Hydrogen bonds: F:E.23, F:G.74, F:S.75, F:G.76, F:G.76, F:K.77, F:T.78, F:S.79
- Salt bridges: F:K.77, F:K.77
- pi-Stacking: F:F.43
ATP.23: 14 residues within 4Å:- Chain B: M.111
- Chain G: W.14, L.22, E.23, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106
- Ligands: MG.22
13 PLIP interactions:13 interactions with chain G- Hydrogen bonds: G:G.74, G:G.74, G:S.75, G:G.76, G:G.76, G:K.77, G:T.78, G:S.79, G:Q.106, G:Q.106
- Salt bridges: G:K.77, G:K.77
- pi-Stacking: G:F.43
ATP.27: 14 residues within 4Å:- Chain G: M.111
- Chain H: W.14, L.22, E.23, F.43, T.73, G.74, S.75, G.76, K.77, T.78, S.79, Q.106
- Ligands: MG.26
13 PLIP interactions:13 interactions with chain H- Hydrogen bonds: H:E.23, H:E.23, H:T.73, H:G.74, H:S.75, H:G.76, H:G.76, H:K.77, H:T.78, H:S.79
- Salt bridges: H:K.77, H:K.77
- pi-Stacking: H:F.43
- 12 x ACY: ACETIC ACID(Non-functional Binders)
ACY.3: 5 residues within 4Å:- Chain A: L.154, G.155, G.158, V.159, T.160
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:G.155, A:V.159, A:T.160
ACY.4: 6 residues within 4Å:- Chain A: D.142, K.145, S.162, Q.165
- Chain D: K.145, Q.165
4 PLIP interactions:2 interactions with chain D, 2 interactions with chain A- Hydrogen bonds: D:Q.165, A:S.162
- Salt bridges: D:K.145, A:K.145
ACY.7: 7 residues within 4Å:- Chain B: L.154, G.155, G.158, V.159, T.160, L.161
- Chain C: L.191
6 PLIP interactions:1 interactions with chain C, 5 interactions with chain B- Hydrophobic interactions: C:L.191
- Hydrogen bonds: B:G.155, B:V.159, B:T.160, B:T.160, B:L.161
ACY.10: 5 residues within 4Å:- Chain C: L.154, G.155, G.158, V.159, T.160
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:G.155, C:V.159, C:T.160
ACY.11: 6 residues within 4Å:- Chain B: K.145, Q.165
- Chain C: D.142, K.145, S.162, Q.165
4 PLIP interactions:2 interactions with chain C, 2 interactions with chain B- Hydrogen bonds: C:S.162, B:Q.165
- Salt bridges: C:K.145, B:K.145
ACY.14: 7 residues within 4Å:- Chain A: L.191
- Chain D: L.154, G.155, G.158, V.159, T.160, L.161
6 PLIP interactions:5 interactions with chain D, 1 interactions with chain A- Hydrogen bonds: D:G.155, D:V.159, D:T.160, D:T.160, D:L.161
- Hydrophobic interactions: A:L.191
ACY.17: 5 residues within 4Å:- Chain E: L.154, G.155, G.158, V.159, T.160
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:G.155, E:V.159, E:T.160
ACY.18: 6 residues within 4Å:- Chain E: D.142, K.145, S.162, Q.165
- Chain H: K.145, Q.165
4 PLIP interactions:2 interactions with chain H, 2 interactions with chain E- Hydrogen bonds: H:Q.165, E:S.162
- Salt bridges: H:K.145, E:K.145
ACY.21: 7 residues within 4Å:- Chain F: L.154, G.155, G.158, V.159, T.160, L.161
- Chain G: L.191
6 PLIP interactions:1 interactions with chain G, 5 interactions with chain F- Hydrophobic interactions: G:L.191
- Hydrogen bonds: F:G.155, F:V.159, F:T.160, F:T.160, F:L.161
ACY.24: 5 residues within 4Å:- Chain G: L.154, G.155, G.158, V.159, T.160
3 PLIP interactions:3 interactions with chain G- Hydrogen bonds: G:G.155, G:V.159, G:T.160
ACY.25: 6 residues within 4Å:- Chain F: K.145, Q.165
- Chain G: D.142, K.145, S.162, Q.165
4 PLIP interactions:2 interactions with chain F, 2 interactions with chain G- Hydrogen bonds: F:Q.165, G:S.162
- Salt bridges: F:K.145, G:K.145
ACY.28: 7 residues within 4Å:- Chain E: L.191
- Chain H: L.154, G.155, G.158, V.159, T.160, L.161
6 PLIP interactions:5 interactions with chain H, 1 interactions with chain E- Hydrogen bonds: H:G.155, H:V.159, H:T.160, H:T.160, H:L.161
- Hydrophobic interactions: E:L.191
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lewis, H.A. et al., Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. Embo J. (2004)
- Release Date
- 2003-12-09
- Peptides
- Cystic fibrosis transmembrane conductance regulator: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
BG
AH
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.00 Å
- Oligo State
- homo-octamer
- Ligands
- 8 x MG: MAGNESIUM ION(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 12 x ACY: ACETIC ACID(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lewis, H.A. et al., Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. Embo J. (2004)
- Release Date
- 2003-12-09
- Peptides
- Cystic fibrosis transmembrane conductance regulator: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
BG
AH
B